Phase II study of Adriamycin with sequential methotrexate and 5-fluorouracil (AMF) in gastric carcinoma
JafferA. Ajani, Pamela Goudeau(The University of Texas MD Anderson Cancer Center), Bernard Levin(The University of Texas MD Anderson Cancer Center), JackS. Faintuch(The University of Texas MD Anderson Cancer Center), JamesL. Abbruzzese(The University of Texas MD Anderson Cancer Center), BruceM. Boman(The University of Texas MD Anderson Cancer Center), M Kanojia(The University of Texas MD Anderson Cancer Center)
Cited by 6